Pharma Ag Novartis, 10% Owner at IDENIX PHARMACEUTICALS INC (IDIX), bought 26,764 shares at $2.96 ($115K) on 2011-11-22, disclosed to the SEC on 2011-12-09.
Open-market purchase of $115k IDIX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.96 | 6,476 | $19K | 16.7% |
| 2 | $4.70 | 20,288 | $95K | 83.3% |
| Total | $4.28 avg | 26,764 | $115K | 100% |
| Filing → |
| IDIX | BUY | 2011-11-22 | $206K | — | Filing → |
| IDIX | BUY | 2010-11-26 | $47K | — | Filing → |
| IDIX | BUY | 2010-09-16 | $91K | — | Filing → |